Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Biomarker TIICs benefitting the prognosis in osteosarcoma patients

National Dairy Research Institute Fellow Recruitment | Online Interview

One-pot Visual RT PCR as a diagnostic test for SARS-CoV-2

Biomarker TIICs benefitting the prognosis in osteosarcoma patients
  • BiotechToday
  • World

Biomarker TIICs benefitting the prognosis in osteosarcoma patients

bioxone October 29, 2020October 28, 2020

Rohit Bhattacharjee, Amity University, Kolkata

Osteosarcoma is a rare malignant bone tumour found in adults and children. It is characterized by early lung metastasis and poor prognosis that seriously the physical and mental health of patients. Chemotherapy and surgery include the main clinical treatment however, recurrence of metastasis remains the poor prognosis. Advances in the study of the tumour microenvironment (TME) opened new directions for the study of osteosarcoma. Recent studies showed that Tumour Infiltrating Immune Cells (TIICs) are associated with osteosarcoma patients’ clinical outcomes. 

CIBERSORTX algorithm was used for calculating the proportion of 22 TIIC types in osteosarcoma samples. Kaplan-Meier curves were drawn to find out the prognostic value of 22 TIIC types. Results revealed that macrophages account for a large proportion of 22 immune cell types, Kaplan-Meier curves indicated naïve B cells and monocytes are associated with poor prognosis of osteosarcoma. B lymphocytes exert a two-way role in tumour – positively regulating tumour immune process by secreting cytokines, antibody production, and negatively regulating tumour immune process by inhibition of proliferated immune-activated T cells.

Also, a nomogram model was created based on immune risk score model which quantified the probability of an event individually and accurately by integrating multiple predictors that are based on multi-factor analysis which showed that TIICs are very closely associated with osteosarcoma prognosis and the immune risk score model created based on TIICs is reliable in osteosarcoma prognosis prediction.

Also read: Pollution and population: tracing to obesity in children?

Source:- 

  1. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07536-3

Cui J, Dean D, Hornicek FJ, Chen Z, Duan Z. The role of extracellular matrix in osteosarcoma progression and metastasis. J Exp Clin Cancer Res. 2020;39:178.

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged B lymphocytes cancer chemotherapy CIBERSORTX cytokines immune risk score model Kaplan-Meier curves metastasis Monocytes nomogram oncology Osteosarcoma Prognosis TIICs tumour microenvironment World

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

One-pot Visual RT PCR as a diagnostic test for SARS-CoV-2

bioxone October 29, 2020

Sumedha Guha, Techno India University The outbreak of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) towards the latter part of 2019 had brought mankind to a screeching halt for some time. The global pandemic that followed in its wake is something that every nation of the world is still grappling hard to recover from. […]

SARS-CoV-2

Related Post

  • BiotechToday
  • World

ANIMAL-FREE MONOCLONAL ANTIBODY- A SUBSTITUTE FOR HYBRIDOMA TECHNOLOGY?

bioxone October 8, 2020October 7, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Hybridoma Technology is known for its’ large-scale production of identical antibodies. Recently, the European Commission’s Joint Research Centre (EC-JRC) urged the government to allow the development of animal-free antibodies for the production of vaccine development. This came after the work done by the Scientific Advisory Committee (ESAC) and claims were […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 to soon face 2 new drugs

bioxone May 30, 2021June 1, 2021

Sampriti Roy, University of Calcutta At this time in the pandemic when we have ongoing vaccination drives, a new development in the pharmaceutical industry could prove to be a step towards enhanced protection and ability to fight against COVID-19 infections. This is the development of two drugs developed by Australian scientists from QIMR Berghofer Medical […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Relation between Metabolic syndrome and head & neck cancer

BioTech Today June 22, 2021June 21, 2021

Shrestha Dutta, Amity University Kolkata Metabolic syndrome (MS) is an association of metabolic irregularities, including hypertension, central obesity, raised amounts of triglycerides, low high-density lipoprotein-cholesterol (HDL-C), and insulin interference. MS or its parts are firmly associated with malignancy and mortality. It has been shown to escalate the occurrence of liver, colorectal, pancreatic, endometrial, and breast […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy